Immunophenotypic subtyping of leukemic cells from Iranian patients with acute lymphoblastic leukaemia: association to disease outcome.
Hossein Asgarian‐Omran(University of Tehran), Fazel Shokri(Tehran University of Medical Sciences), Mahmood Jeddi‐Tehrani, Jalal Khoshnoodi(University of Tehran), Hodjatallah Rabbani(Biotechnology Research Center), Parvaneh Vossough(Iran University of Medical Sciences), Ramzan A Sharifian(University of Tehran), Tahereh Shahrestani(University of Tehran), Mahdi Shabani(Shiraz University of Medical Sciences), Abdolfattah Sarafnejad(University of Tehran), Mohammad Faranoush(Iran University of Medical Sciences)
Cited by 15
Related Papers
Overexpression of Orphan Receptor Tyrosine Kinase <i>Ror1</i> as a Putative Tumor-Associated Antigen in Iranian Patients with Acute Lymphoblastic Leukemia
|Tumor Biology|2007|46
Expression profile of orphan receptor tyrosine kinase (<i>ROR1</i>) and Wilms' tumor gene 1 (<i>WT1</i>) in different subsets of B-cell acute lymphoblastic leukemia
|Leukemia & lymphoma/Leukemia and lymphoma|2008|46
The Prognostic Value of Thrombocytopenia in COVID-19 Patients; a Systematic Review and Meta-Analysis.
|PubMed|2020|45
Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin
|Biomedicine & Pharmacotherapy|2017|31
Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura
|The Indian Journal of Pediatrics|2008|30